Aflibercept recalls

The FDA has published 3 recalls involving Aflibercept since 2012. The latest was reported on 5 Jun 2024. Most were for sterility. Regeneron Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2012

Last 12 months0reported

Class I00% of total

Ongoing0latest 5 Jun 2024

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why aflibercept is recalled

Sterility3100%

Companies

By year

2024267%
2012133%

All aflibercept recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
5 Jun 2024Drug	CLASS II	Eylea, (aflibercept) Injection, For Intravitreal injection recalledEylea	Regeneron Pharmaceuticals	Sterility	Nationwide
8 May 2024Drug	CLASS II	Eylea, (aflibercept) Injection, 2 mg of a 40mg/mL solution) recalledEylea	Regeneron Pharmaceuticals	Sterility	Nationwide
22 Aug 2012Drug	CLASS II	Aflibercept, Sdpf - Syringe, 5/16") 40mg/ML Injectable recalled	Franck's Lab Inc., d.b.a. Franck's Compounding Lab	Sterility	Nationwide

Should you stop taking Aflibercept?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.